title: Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.
authors.affiliation: Department of Dermatology, Universitätsmedizin Mainz, Langenbeckstrasse 1, Mainz.
authors.forename: A
authors.initials: A
authors.lastname: Groffik
authors.forename: H
authors.initials: H
authors.lastname: Mitzel-Kaoukhov
authors.forename: M
authors.initials: M
authors.lastname: Magerl
authors.forename: M
authors.initials: M
authors.lastname: Maurer
authors.forename: P
authors.initials: P
authors.lastname: Staubach
mesh_terms: D000328:Adult; D000368:Aged; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D016896:Treatment Outcome; D014581:Urticaria / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab